Empowered Funds LLC Boosts Holdings in Colgate-Palmolive (NYSE:CL)

Empowered Funds LLC increased its position in Colgate-Palmolive (NYSE:CL - Free Report) by 22.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 69,602 shares of the company's stock after buying an additional 12,797 shares during the quarter. Empowered Funds LLC's holdings in Colgate-Palmolive were worth $7,225,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in CL. E Fund Management Hong Kong Co. Ltd. bought a new stake in shares of Colgate-Palmolive during the second quarter valued at approximately $25,000. Continuum Advisory LLC boosted its holdings in shares of Colgate-Palmolive by 46.5% during the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company's stock valued at $38,000 after buying an additional 125 shares in the last quarter. Reston Wealth Management LLC purchased a new stake in shares of Colgate-Palmolive in the 3rd quarter worth about $42,000. Capital Performance Advisors LLP bought a new position in shares of Colgate-Palmolive in the 3rd quarter worth about $53,000. Finally, Gradient Investments LLC lifted its position in Colgate-Palmolive by 150.4% during the 2nd quarter. Gradient Investments LLC now owns 666 shares of the company's stock valued at $65,000 after acquiring an additional 400 shares during the period. 80.41% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on CL shares. TD Cowen cut their price objective on shares of Colgate-Palmolive from $115.00 to $110.00 and set a "buy" rating on the stock in a report on Monday, October 28th. Barclays upped their price target on Colgate-Palmolive from $91.00 to $96.00 and gave the stock an "equal weight" rating in a research note on Monday, July 29th. Piper Sandler began coverage on Colgate-Palmolive in a research note on Tuesday, September 24th. They set an "overweight" rating and a $121.00 price objective for the company. Jefferies Financial Group cut Colgate-Palmolive from a "buy" rating to a "hold" rating and cut their target price for the stock from $103.00 to $95.00 in a research note on Wednesday, July 24th. Finally, UBS Group raised their price target on Colgate-Palmolive from $119.00 to $122.00 and gave the company a "buy" rating in a report on Wednesday, September 4th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and thirteen have issued a buy rating to the company's stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average price target of $105.11.

Colgate-Palmolive Stock Performance

Shares of CL stock traded up $2.11 on Friday, reaching $93.56. The stock had a trading volume of 7,328,993 shares, compared to its average volume of 4,723,827. The stock has a market cap of $76.44 billion, a P/E ratio of 26.81, a price-to-earnings-growth ratio of 3.34 and a beta of 0.42. The company has a debt-to-equity ratio of 9.46, a quick ratio of 0.68 and a current ratio of 1.04. Colgate-Palmolive has a 1 year low of $75.17 and a 1 year high of $109.30. The company has a 50 day simple moving average of $99.31 and a 200 day simple moving average of $98.54.

Colgate-Palmolive Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Friday, October 18th were given a dividend of $0.50 per share. The ex-dividend date of this dividend was Friday, October 18th. This represents a $2.00 annualized dividend and a yield of 2.14%. Colgate-Palmolive's dividend payout ratio (DPR) is 57.31%.

Insider Buying and Selling at Colgate-Palmolive

In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of the firm's stock in a transaction that occurred on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now owns 36,726 shares in the company, valued at approximately $3,456,283.86. This trade represents a 55.29 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Martina Hundmejean sold 2,313 shares of Colgate-Palmolive stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $103.86, for a total transaction of $240,228.18. Following the transaction, the director now directly owns 11,755 shares in the company, valued at $1,220,874.30. This represents a 16.44 % decrease in their position. The disclosure for this sale can be found here. 0.34% of the stock is owned by corporate insiders.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.